No Level 4 CDC Travel Health Notices currently exist, as official monitoring shows only Level 3 advisories for Ebola in the Democratic Republic of the Congo and Level 2 notices for malaria in Mayotte plus recent Ebola cases in Uganda. Measles outbreaks in the U.S. have produced nearly 2,000 confirmed cases through May 2026, yet remain below thresholds requiring extreme travel restrictions. Diphtheria and dengue activity in Africa and elsewhere stays at Level 1 or 2, reflecting contained transmission without the extreme health risks that historically trigger “Avoid All Travel” designations. Surveillance data through early June 2026 indicate stable conditions unlikely to escalate rapidly enough for a new Level 4 notice by year-end.
Resumo experimental gerado por IA com dados do Polymarket. Isto não é aconselhamento de trading e não tem qualquer papel na resolução deste mercado. · AtualizadoCDC emite aviso de Nível 4 até 31 de dezembro?
Sim
$71,848 Vol.
$71,848 Vol.
Sim
$71,848 Vol.
$71,848 Vol.
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
Mercado Aberto: Jan 19, 2026, 3:15 PM ET
Resolver
0x65070BE91...A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
Resolver
0x65070BE91...No Level 4 CDC Travel Health Notices currently exist, as official monitoring shows only Level 3 advisories for Ebola in the Democratic Republic of the Congo and Level 2 notices for malaria in Mayotte plus recent Ebola cases in Uganda. Measles outbreaks in the U.S. have produced nearly 2,000 confirmed cases through May 2026, yet remain below thresholds requiring extreme travel restrictions. Diphtheria and dengue activity in Africa and elsewhere stays at Level 1 or 2, reflecting contained transmission without the extreme health risks that historically trigger “Avoid All Travel” designations. Surveillance data through early June 2026 indicate stable conditions unlikely to escalate rapidly enough for a new Level 4 notice by year-end.
Resumo experimental gerado por IA com dados do Polymarket. Isto não é aconselhamento de trading e não tem qualquer papel na resolução deste mercado. · Atualizado
Cuidado com os links externos.
Cuidado com os links externos.
Frequently Asked Questions